发明授权
- 专利标题： Compositions and methods for vaccinating against HSV-2
- 专利标题（中）： 针对HSV-2接种疫苗的组合物和方法
-
申请号： US13843176申请日： 2013-03-15
-
公开(公告)号： US08828408B2公开(公告)日： 2014-09-09
- 发明人: Adrian Vilalta , Michal Margalith , Lichun Dong , David M. Koelle
- 申请人： The University of Washington , Vical Incorporated
- 申请人地址： US CA San Diego US WA Seattle
- 专利权人： Vical Incorporated,The University of Washington
- 当前专利权人： Vical Incorporated,The University of Washington
- 当前专利权人地址： US CA San Diego US WA Seattle
- 代理机构： Sughrue Mion, PLLC
- 主分类号： A61K39/245
- IPC分类号： A61K39/245 ; C07K14/005 ; C12N15/38 ; C12N15/00 ; A61K39/00
摘要：
This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP13/14 polypeptides.
公开/授权文献
- US20130273108A1 COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2 公开/授权日：2013-10-17
信息查询
